08Nov 2024
Methotrexate Reduces Pain and Stiffness in Knee Osteoarthritis

Methotrexate Reduces Pain and Stiffness in Knee Osteoarthritis

In a randomized, double-blind, placebo-controlled trial conducted across 15 UK musculoskeletal clinics, methotrexate significantly reduced pain, stiffness, and improved function in patients with knee osteoarthritis (KOA). Among 155 participants, average knee pain decreased from 6.4 to 5.1 on the numerical rating scale (NRS) over 6 months in the methotrexate group, compared to 6.8 to 6.2 in the placebo group, resulting in a 0.79-point NRS pain reduction in favor of methotrexate (P = 0.030). Methotrexate also improved knee stiffness and function scores. The trial supported a dose-response effect, with adherence to methotrexate correlating to better outcomes. Four unrelated serious adverse events occurred. These findings suggest methotrexate could offer significant symptomatic relief for KOA patients alongside standard treatments.

  • #family health
  • #orthopaedics

Like

Save

Share